Podemos atuar preventivamente para evitar que os pacientes portadores de COVID-19 evoluam de forma mais grave? / Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
J. vasc. bras
;
19: e20200057, 2020. tab, graf
Article
in Portuguese
| LILACS
| ID: biblio-1135112
RESUMO
Resumo Muitos pacientes com COVID-19 apresentam complicações tromboembólicas que acabam piorando seu prognóstico. Os autores propõem uma modificação no escore CHA2DS2-VASc, incluindo 1 ponto para COVID-19, para, desse modo, indicar profilaxia de eventos tromboembólicos antes do agravamento do quadro. As vantagens dessa modificação seriam evitar a piora do paciente por problemas tromboembólicos, bem como a necessidade de internação em unidade de tratamento intensivo e de ventilação mecânica, e diminuir a mortalidade.
ABSTRACT
Abstract Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient's condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thrombosis
/
COVID-19
Type of study:
Etiology study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
Portuguese
Journal:
J. vasc. bras
Journal subject:
Cardiology
Year:
2020
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal Fluminense/BR
Similar
MEDLINE
...
LILACS
LIS